:format(webp)/cdn.mskdoctors.com/storage/2026/7/K3jsBbp5nFdNAw90o7QvOl2QvEgIxbFS.jpg)
ACI for Ankle Cartilage DefectsMicrofracture produces fibrocartilage that deteriorates within two to three years for ankle cartilage lesions over 15 mm in diameter; autologous chondrocyte implantation regenerates more durable, hyaline-like cartilage that more closely resembles native tissue for larger defects.Microfracture produces fibrocartilage that deteriorates within two to three years for ankle cartilage lesions over 15 mm in diameter; autologous chondrocyte implantation regenerates more durable, hyaline-like cartilage that more closely resembles native tissue for larger defects.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/eKvTOqV3tS5DTB7U9LfhDRFAQjP6VyJq.jpg)
ChondroFiller injection costs in the UK and EuropeChondroFiller costs £3,000–£8,000 in the UK, scaled by defect size, delivered as an ultrasound-guided outpatient injection with no surgery or anaesthetic.ChondroFiller costs £3,000–£8,000 in the UK, scaled by defect size, delivered as an ultrasound-guided outpatient injection with no surgery or anaesthetic.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/3aSyR63ySuJZmocQzHqqMPPUfTOGrn79.jpg)
ChondroFiller for Shoulder Cartilage DefectsFocal shoulder cartilage defects are now treatable with a single ultrasound-guided collagen injection that recruits the body's own repair cells, forming hyaline-like tissue over 12 months without surgery or general anaesthetic.Focal shoulder cartilage defects are now treatable with a single ultrasound-guided collagen injection that recruits the body's own repair cells, forming hyaline-like tissue over 12 months without surgery or general anaesthetic.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/QrfuPSrluQSuTfY26E2s7bPfm9fOFncs.jpg)
ChondroFiller injection safety: what the evidence showsOver 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).Over 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).
:format(webp)/cdn.mskdoctors.com/storage/2026/7/74YTQQTyjHqGW0SCQyz2DVitXQ2VE6a3.jpg)
How single-stage ACI differs from MACIMACI repairs cartilage defects over two operations, with weeks between them for external cell expansion; STACi compresses the entire process—harvesting, processing, and implantation—into a single surgical session.MACI repairs cartilage defects over two operations, with weeks between them for external cell expansion; STACi compresses the entire process—harvesting, processing, and implantation—into a single surgical session.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/m5k3lBRdo7ye9In2EqmADJi2arAPrSmx.jpg)
ChondroFiller injection cost in the UKMost patients pay £3,000 for ChondroFiller injection, an all-inclusive price covering consultation, imaging, ultrasound-guided injection, antibiotics, and follow-up; the cost premium reflects Class III medical-device status, not an arbitrary markup.Most patients pay £3,000 for ChondroFiller injection, an all-inclusive price covering consultation, imaging, ultrasound-guided injection, antibiotics, and follow-up; the cost premium reflects Class III medical-device status, not an arbitrary markup.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/ETKg1ueF5BBKIau7DxGIoPsVzI5r2krh.jpg)
ChondroFiller and Arthrosamid serve different knee conditionsChondroFiller recruits progenitor cells to rebuild focal cartilage defects, whilst Arthrosamid provides permanent cushioning for diffuse osteoarthritis by integrating into the joint capsule; the choice between them follows from what MRI reveals about the damage pattern, not from symptom severity.ChondroFiller recruits progenitor cells to rebuild focal cartilage defects, whilst Arthrosamid provides permanent cushioning for diffuse osteoarthritis by integrating into the joint capsule; the choice between them follows from what MRI reveals about the damage pattern, not from symptom severity.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/rgOU5joVFIvQSkaY3S921m8v6ZjDLgSd.jpg)
Who qualifies for a ChondroFiller injectionChondroFiller targets ICRS Grade III–IV cartilage damage, where more than half the cartilage is lost or bone is exposed. Delivered as an ultrasound-guided outpatient injection, the collagen scaffold recruits the patient's own progenitor cells to initiate repair.ChondroFiller targets ICRS Grade III–IV cartilage damage, where more than half the cartilage is lost or bone is exposed. Delivered as an ultrasound-guided outpatient injection, the collagen scaffold recruits the patient's own progenitor cells to initiate repair.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/FW4tjtddXKJjjZCudW3Svp32DiOQPQEU.jpg)
ChondroFiller for focal knee defects, not osteoarthritisChondroFiller is an injectable collagen scaffold that recruits a patient's own progenitor cells for cartilage repair. It works only on focal defects; chronic inflammation and cell depletion in osteoarthritis eliminate the biological conditions it requires.ChondroFiller is an injectable collagen scaffold that recruits a patient's own progenitor cells for cartilage repair. It works only on focal defects; chronic inflammation and cell depletion in osteoarthritis eliminate the biological conditions it requires.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/2hoqnEBJW6PS9qANeFgmU7H7tZecPFZC.jpg)
Why ChondroFiller requires a specialist injection pathwayChondroFiller, a collagen matrix, self-polymerises within three to five minutes of injection; needle placement under ultrasound guidance must therefore be exact, as repositioning becomes impossible once gelation begins and structural repair unfolds over six to twelve months.ChondroFiller, a collagen matrix, self-polymerises within three to five minutes of injection; needle placement under ultrasound guidance must therefore be exact, as repositioning becomes impossible once gelation begins and structural repair unfolds over six to twelve months.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/hni8MzqBb5F58Pemnb9wF3BSQI0fYlj6.jpg)
ChondroFiller injection vs surgery for focal knee cartilageAn ultrasound-guided collagen injection activates the joint's own regenerative cells to repair focal knee cartilage defects; 70–85% of treated patients report meaningful symptom relief within three to five years.An ultrasound-guided collagen injection activates the joint's own regenerative cells to repair focal knee cartilage defects; 70–85% of treated patients report meaningful symptom relief within three to five years.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/UY0InSBaoOinSJHR9T3qmZrV7DMIQOXA.jpg)
ChondroFiller vs PRP for focal cartilage defectsFocal cartilage defects and diffuse cartilage loss are different problems requiring different solutions. ChondroFiller, a collagen scaffold, physically occupies and stabilises focal voids, recruiting repair cells over 12–24 months. PRP releases growth factors to reduce inflammation but cannot fill a structural gap. Imaging reveals which mechanism addresses the patient's underlying…Focal cartilage defects and diffuse cartilage loss are different problems requiring different solutions. ChondroFiller, a collagen scaffold, physically occupies and stabilises focal voids, recruiting repair cells over 12–24 months. PRP releases growth factors to reduce inflammation but cannot fill a structural gap. Imaging reveals which mechanism addresses the patient's underlying problem.
